• No results found

[PDF] Top 20 Protective mechanisms of flavonoids in Parkinson's disease

Has 10000 "Protective mechanisms of flavonoids in Parkinson's disease" found on our website. Below are the top 20 most common "Protective mechanisms of flavonoids in Parkinson's disease".

Protective mechanisms of flavonoids in Parkinson's disease

Protective mechanisms of flavonoids in Parkinson's disease

... Polyphenol flavonoids are found ubiquitously in a wide range of fruits and vegetables such as apple skin, celery, oranges, onion, mango, apples, and buckwheat, as well as food and beverages derived from plants ... See full document

15

Morning akinesia in Parkinson's disease: challenges and solutions

Morning akinesia in Parkinson's disease: challenges and solutions

... Abstract: Motor complications of Parkinson’s disease (PD) have been reported to occur after a few years of treatment with levodopa (L-dopa). Morning akinesia is a delayed ON of the first L-dopa daily dose, ... See full document

7

Spotlight on olfactory dysfunction in Parkinson's disease

Spotlight on olfactory dysfunction in Parkinson's disease

... defense mechanisms, secondary atrophy of the OB, decreased brain weight, cortical thickness, decrements in the volume of the hippocampus, amygdala, piriform cortex and frontal poles of the brain, and diminished ... See full document

9

Rasagiline in treatment of Parkinson’s disease

Rasagiline in treatment of Parkinson’s disease

... surrogate disease markers (LeWitt 2006; Biglan and Ravina 2007; Hung and Schwarzschild ...Parkinson’s disease (Hirsch et al 1999), leading to the pos- sibility of utilizing anti-apoptotic agents as ... See full document

10

The resurgence of neurotransmitter modulation in Parkinson’s disease with safinamide

The resurgence of neurotransmitter modulation in Parkinson’s disease with safinamide

... in PD drug research are caused by various obvious but only partially scrutinized reasons. They may complement each other. The etiology of sporadic forms of PD is still unknown and various mechanisms of neuronal ... See full document

7

Sleep disorders in Parkinson’s disease

Sleep disorders in Parkinson’s disease

... 100 PD patients (50 unselected, consecutive patients matched for age, sex and body mass index and 50 patients referred for sleepiness) and 50 in-hospital controls. Subjects underwent a video-polysomnography, and sleep ... See full document

6

Nonmotor symptoms in Parkinson's disease: classification and management

Nonmotor symptoms in Parkinson's disease: classification and management

... correlates with poorer quality of life; it can also be treatment resistant. The mechanisms underlying pain in PD are not totally clear. Pain process in PD might be affected at multiple levels, from the ... See full document

10

Neuropsychiatric symptoms in untreated Parkinson’s disease

Neuropsychiatric symptoms in untreated Parkinson’s disease

... Parkinson’s disease (PD) and may precede and exceed motor symptoms as major factors impacting disease course and quality of ...early disease stages, premotor and early motor phases were separately ... See full document

12

Estrogen-related and other disease diagnoses preceding Parkinson’s disease

Estrogen-related and other disease diagnoses preceding Parkinson’s disease

... preceding disease as well as important risk modifiers of PD and other diseases such as ...the disease process as the understanding of causal ...preceding disease or from common causal ... See full document

18

Cognitive deficits in Parkinson’s disease: current perspectives

Cognitive deficits in Parkinson’s disease: current perspectives

... The major pathological driver of cognitive decline in PD is believed to be the presence of Lewy bodies and Lewy neurites within the limbic system and neocortex, although AD-related pathology – tau neurofibrillary tangles ... See full document

11

Stabilometric analysis in individuals with parkinson`s disease

Stabilometric analysis in individuals with parkinson`s disease

... ith PD tend to have larger COP sway, because they present more postural instabillity. In addition, several different factors are involved which cause postural instability, among them, anxiety is related to the fear of ... See full document

6

An update on the management of young-onset Parkinson's disease

An update on the management of young-onset Parkinson's disease

... putative protective effect smoking might have on PD ...the protective effects of smoking were not enough to overcome all other factors leading to ... See full document

10

Parkinson’s disease-associated melanin steal

Parkinson’s disease-associated melanin steal

... concept that cytokine function is important enough to pref- erentially steal the precursors required for catecholamine synthesis and optimal function. A more compelling argument is that the various forms of melanin are ... See full document

7

Advances with microRNAs in Parkinson’s disease research

Advances with microRNAs in Parkinson’s disease research

... In the past few years, the field of miRNA study has revealed highly significant molecular mechanisms relevant to PD pathogenesis. Emerging evidence strongly indicates the important role of miRNAs in the ... See full document

11

Animal models of Parkinson's disease and their applications

Animal models of Parkinson's disease and their applications

... 95. Guo SH, Yan JQ, Yang TB, et al. Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson’s disease through inhibition of ROS-NO pathway. Biol Psychiatry. 2007;62:1353–1362. 96. ... See full document

10

Stem cells and regenerative therapies for Parkinson’s disease

Stem cells and regenerative therapies for Parkinson’s disease

... Parkinson’s disease (PD) therapy is the pharmacological replacement of the loss of the dopaminergic nigrostriatal pathway using drugs such as dopamine agonists and ... See full document

14

Available and emerging treatments for Parkinson’s disease: a review

Available and emerging treatments for Parkinson’s disease: a review

... Abstract: Parkinson’s disease is a commonly encountered neurodegenerative disorder primarily found in aged populations. A number of medications are available to control symptoms, although these are less effective ... See full document

14

Safinamide: an add-on treatment for managing Parkinson’s disease

Safinamide: an add-on treatment for managing Parkinson’s disease

... a disease duration of at least 3 years, a preexisting stable levodopa regimen and occurrence of motor fluctuations with an “OFF” time duration for at least ... See full document

11

STUDIES OF THE EFFECTS OF FLAVONOIDS ON ROENTGEN IRRADIATION DISEASE  II  COMPARISON OF THE PROTECTIVE INFLUENCE OF SOME FLAVONOIDS AND VITAMIN C IN DOGS

STUDIES OF THE EFFECTS OF FLAVONOIDS ON ROENTGEN IRRADIATION DISEASE II COMPARISON OF THE PROTECTIVE INFLUENCE OF SOME FLAVONOIDS AND VITAMIN C IN DOGS

... The results from careful hematological studies can be summarized as follows: averaged values from dogs treated with the substances listed in Table III were identical with those of the un[r] ... See full document

7

Treatment of Nonmotor Symptoms in Parkinson's Disease

Treatment of Nonmotor Symptoms in Parkinson's Disease

... CHAUDHURI, K. R., MARTINEZ-MARTIN, P., BROWN, R. G., SETHI, K., STOCCHI, F., ODIN, P., ONDO, W., ABE, K., MACPHEE, G., MACMAHON, D., BARONE, P., RABEY, M., FORBES, A., BREEN, K., TLUK, S., NAIDU, Y., OLANOW, W., ... See full document

27

Show all 10000 documents...